Loading
Latest filing published 25 Sept 2017 for Alliqua BioMedical, Inc., €24k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Bradford Barton in Alliqua BioMedical, Inc. Between 6 February 2015 and 21 September 2017, the trades on record add up to 10 filings.
Every open-market trade on record is a purchase: 3 purchases worth €56k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 7 share grants. In 2017 alone, the filings show 1 purchase and no sales.
Half of the purchases are above €14k and half below.
On 25 September 2017 came the latest disclosure, a share grant for €24k in Alliqua BioMedical, Inc. The most recent open-market purchase was published on 4 April 2017, 3,489 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations